SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 409 JPY | -1.45% |
|
+4.34% | -12.23% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 15 M€ | +6.12% | ||
| 0.15% | 67,864 M€ | +13.30% | ||
| 0.13% | 31,732 M€ | +13.33% | - | |
| 0.13% | 1,198 M€ | +12.32% | - | |
| 0.11% | 1,120 M€ | +0.69% | ||
| 0.10% | 16,729 M€ | +13.35% | - | |
| 0.06% | 4 M€ | +13.95% | ||
| 0.06% | 60 M€ | +13.50% | ||
| 0.05% | 14 M€ | +15.50% | ||
| 0.05% | 73 M€ | +11.61% | ||
| 0.03% | 5,115 M€ | +13.13% | ||
| 0.03% | 10,207 M€ | +12.87% | ||
| 0.03% | 18 M€ | +16.15% | - | |
| 0.02% | 144,586 M€ | +13.32% | ||
| 0.02% | 20,721 M€ | +12.51% | - | |
| 0.02% | 66,066 M€ | +13.68% | - | |
| 0.01% | 773 M€ | -.--% | - | |
| 0.01% | 7 M€ | +1.16% | - | |
| 0.00% | 31 M€ | +2.38% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +5.05% | - | |
| 0.00% | 389 M€ | +5.99% | - | |
| 0.00% | 39 M€ | +2.90% | - | |
| 0.00% | 302 M€ | +3.83% | - | |
| 0.00% | 34 M€ | +2.67% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
409
JPY
Average target price
333.8
JPY
Spread / Average Target
-18.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.23% | 1.07B | |
| +27.16% | 659B | |
| +27.68% | 557B | |
| -4.55% | 359B | |
| +16.49% | 322B | |
| +9.62% | 297B | |
| +5.87% | 215B | |
| +4.93% | 210B | |
| -6.01% | 200B | |
| -8.35% | 149B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.
